Sartorius/KMI go global
Sartorius North America and KMI/Parexel International have formed an alliance that will improve the geographic reach of their biopharmaceutical production and consultancy services.
Sartorius North America and KMI/Parexel International have formed an alliance that will improve the geographic reach of their biopharmaceutical production and consultancy services.
Medarex of the USA, a specialist in producing fully-human antibodies, has entered into two new agreements aimed at improving the properties of its drug candidates.
An alliance between two German companies - 4SC and SWITCH Biotech - has been set up to focus on the discovery of small-molecule compounds for the treatment of psoriasis.
Researchers have established the cause of the leukaemia which developed in two young patients taking part in a pioneering gene therapy trial to treat the fatal 'baby-in-a-bubble' syndrome.
Dutch pharmaceuticals, chemicals and coatings group Akzo Nobel has reported a 23 per cent decline in third-quarter earnings, roughly in line with expectations, on the back of continued pressure on its pharmaceuticals division.
Ambion has developed technique that allows easier monitoring of short RNA sequences in a variety of sample types and is 100-500 more sensitive than Northern blot analysis.